FDAnews
www.fdanews.com/articles/124319-optimer-pharma-rsquo-s-antibiotic-succeeds-in-late-stage-trial-again

Optimer Pharma’s Antibiotic Succeeds in Late-Stage Trial Again

February 5, 2010
Optimer Pharmaceuticals Inc. announced positive results from the second of two late-stage trials of its investigational antibiotic, Fidaxomicin in patients with CDI (Clostridium difficile infection).
RTTNews